Tenderwize
Back to tender search

Non-exclusive rebate agreement for Filgrastim

GWQ ServicePlus AG·Düsseldorf, Germany·Deadline Nov 10, 2027 · 449 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Filgrastim.

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Submission is not electronic and the notice indicates postal submission; missing or late physical delivery could invali...

Important procurement documents are referenced on the portal but were not included in the provided extracted text, so f...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Supply of pharmaceutical products, specifically rebate agreements for Filgrastim.
  • Conclusion of non-exclusive rebate agreements under § 130a Abs. 8 SGB V.
Show full summary

Open procedure notice for a pharmaceutical supply arrangement in Germany concerning non-exclusive rebate agreements for the active substance Filgrastim. The notice indicates a join-at-any-time model for interested pharmaceutical companies, with contract start planned for 2026-01-01 and a submission/mailing deadline for signed documents on 2025-12-10 to enable first notification on 2026-01-01. No contract value is stated. Submission is not electronic and appears to be postal. Procurement documents are referenced on the GWQ portal, but only the XML notice text was provided for analysis.

Risks

Submission is not electronic and the notice indicates postal submission; missing or late physical delivery could invali...

Important procurement documents are referenced on the portal but were not included in the provided extracted text, so f...

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Signed contract in duplicate.
  • Proof of marketing authorization via extract from the public part of the AMIce database.

Administrative

  • Signed self-declaration (Annex 3).

Buyer

Location

Düsseldorf, DEU

Buyer profile

Open profile

Identifier

DE258895210

Activity

Health

Lots (1)

LOT-0000

Non-exclusive rebate agreement for Filgrastim

Single lot for concluding non-exclusive rebate agreements under § 130a(8) SGB V for the active substance Filgrastim. The model is described as open to all interested pharmaceutical companies on equal terms during the contract term. The notice says participating sickness funds may vary by specialist lot, but only one lot is structured here and no separate lot breakdown is provided in the structured data.

SuppliesEU fundedElectronic submission

Location

DEA11, Germany

Duration

Dec 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 10, 2027

Procurement Details

Publication date
17 Nov 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
765198-2025

Similar tenders